A
IMVT icon

AlphaQuest’s Immunovant IMVT Stock Holding History

AlphaQuest’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,326
Closed -$237K – 974
2025
Q4 		$237K Sell
9,326
-3,578
-28% -$79.8K 0.01% 1362
2025
Q3 		$208K Buy
12,904
+12,010
+1,343% +$194K 0.01% 1382
2025
Q2 		$14.3K Sell
894
-4,806
-84% -$72.7K ﹤0.01% 1827
2025
Q1 		$97.4K Buy
5,700
+5,346
+1,510% +$112K 0.01% 1310
2024
Q4 		$8.77K Buy
354
+342
+2,850% +$9.7K ﹤0.01% 1478
2024
Q3 		$342 Sell
12
-2,598
-100% -$76.6K ﹤0.01% 1773
2024
Q2 		$68.9K Buy
2,610
+1,786
+217% +$50.8K 0.01% 1021
2024
Q1 		$26.6K Buy
824
+823
+82,300% +$30K ﹤0.01% 1004
2023
Q4 		$42 Buy
+1
New +$37 ﹤0.01% 1055

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return